ES2130522T3 - Compuestos de vitamina d y metodo para preparar estos compuestos. - Google Patents

Compuestos de vitamina d y metodo para preparar estos compuestos.

Info

Publication number
ES2130522T3
ES2130522T3 ES95203412T ES95203412T ES2130522T3 ES 2130522 T3 ES2130522 T3 ES 2130522T3 ES 95203412 T ES95203412 T ES 95203412T ES 95203412 T ES95203412 T ES 95203412T ES 2130522 T3 ES2130522 T3 ES 2130522T3
Authority
ES
Spain
Prior art keywords
sub
group
compounds
diseases
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95203412T
Other languages
English (en)
Inventor
Antonio Mourino
Jose Antonio Martinez
Los Angeles Rey Maria De
Juan Granja
Sebastianus J Halkes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duphar International Research BV
Original Assignee
Duphar International Research BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar International Research BV filed Critical Duphar International Research BV
Application granted granted Critical
Publication of ES2130522T3 publication Critical patent/ES2130522T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE VITAMINA D DE LA FORMULA GENERAL: EN LA QUE R{SUB,1} ES UN ATOMO DE HIDROGENO O UN GRUPO HIDROXI; R{SUB,2} ES UN GRUPO ALQUILO (C{SUB,1}-C{SUB,3}), UN GRUPO HIDROXIALQUILO (C{SUB,1}-C{SUB,3}), UN GRUPO ALCOXIMETILO (C{SUB,1}-C{SUB,2}) O UN GRUPO ALQUENILO (C{SUB,2}-C{SUB,3}) O ALQUINILO; N ES 0 O 1; R{SUB,3} ES UN RADICAL HIDROCARBURO (C{SUB,3}-C{SUB,7}) U OXAHIDROCARBURO ALIFATICO LINEAL O RAMIFICADO, SATURADO O INSATURADO, SUSTITUIDO O INSUSTITUIDO; R{SUB,4} ES UN GRUPO ALQUILO (C{SUB,1}-C{SUB,6}) O UN GRUPO CICLOALQUILO (C{SUB,3}-C{SUB,6}); Y A Y B CON CADA UNO, INDIVIDUALMENTE, ATOMOS DE HIDROGENO O GRUPOS METILO, O A Y B FORMAN JUNTOS UN GRUPO METILENO. LOS PRESENTES COMPUESTOS SON DE APLICACION EN EL CAMPO DE LA COSMETICA Y LA PRACTICA FARMACOTERAPEUTICA HUMANA Y VETERINARIA PARA EL TRATAMIENTO DE ENFERMEDADES DE LA PIEL O DE LOS HUESOS, ENFERMEDADES RELACIONADAS CON LA DIFERENCIACION CELULAR/PROLIFERACION CELULAR, DESEQUILIBRIOS EN ELSISTEMA INMUNE Y ENFERMEDADES INFLAMATORIAS.
ES95203412T 1994-12-14 1995-12-08 Compuestos de vitamina d y metodo para preparar estos compuestos. Expired - Lifetime ES2130522T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94203616 1994-12-14

Publications (1)

Publication Number Publication Date
ES2130522T3 true ES2130522T3 (es) 1999-07-01

Family

ID=8217451

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95203412T Expired - Lifetime ES2130522T3 (es) 1994-12-14 1995-12-08 Compuestos de vitamina d y metodo para preparar estos compuestos.

Country Status (9)

Country Link
US (1) US5929056A (es)
EP (1) EP0717034B1 (es)
JP (1) JP4036490B2 (es)
AT (1) ATE178596T1 (es)
CA (1) CA2164916A1 (es)
DE (1) DE69508895T2 (es)
DK (1) DK0717034T3 (es)
ES (1) ES2130522T3 (es)
IL (1) IL116326A (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10316652A (ja) * 1997-05-02 1998-12-02 Duphar Internatl Res Bv １６−デヒドロビタミンｄ化合物の製造方法
GB9721156D0 (en) * 1997-10-06 1997-12-03 Leo Pharm Prod Ltd Novel vitamin d analogues
DE19935771A1 (de) 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
WO2003026445A1 (en) * 2001-09-27 2003-04-03 The Coca-Cola Company Vitamin fortification of foodstuffs
ATE469127T1 (de) * 2004-11-22 2010-06-15 Wisconsin Alumni Res Found 17,20(z)-dehydro-vitamin-d-analoge und deren verwendungen
US8193169B2 (en) * 2006-04-06 2012-06-05 Wisconsin Alumni Research Foundation (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
US8193170B2 (en) 2008-07-10 2012-06-05 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US7648974B1 (en) * 2008-07-10 2010-01-19 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 3,2-dihydrofuran ring
US7888339B2 (en) * 2008-07-10 2011-02-15 Wisconsin Alumni Research Foundation 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
US7879829B2 (en) * 2008-07-10 2011-02-01 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 1,2-dihydrofuran ring
US8222236B2 (en) * 2008-07-10 2012-07-17 Wisconsin Alumni Research Foundation 2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
US7713953B2 (en) * 2008-07-10 2010-05-11 Wisconsin Alumni Research Foundation 2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
US7893043B2 (en) * 2008-07-10 2011-02-22 Wisconsin Alumni Research Foundation 2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs
US8399439B2 (en) 2008-07-10 2013-03-19 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
SG2014006324A (en) * 2009-01-27 2014-03-28 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
CN106265695B (zh) 2009-08-14 2021-05-07 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
MX2012003883A (es) 2009-10-02 2012-06-27 Wisconsin Alumni Res Found Analogos de (20s,22e)-2-metileno-19-nor-22-ene-1a,25-dihidroxovita mina d3.
US8217023B2 (en) 2009-10-02 2012-07-10 Wisconsin Alumni Research Foundation 19-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring
JP6059716B2 (ja) 2011-06-03 2017-01-11 ウイスコンシン アラムニ リサーチ ファンデーション （２２Ｅ）−２−メチレン−２６，２７−シクロ−２２−デヒドロ−１α−ヒドロキシ−１９−ノルビタミンＤ３誘導体
US10479764B2 (en) 2011-06-28 2019-11-19 Wisconsin Alumni Research Foundation 2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
WO2013012644A1 (en) 2011-07-18 2013-01-24 Wisconsin Alumni I Research Foundation 2-methylene-20(21)-dehydro-19,24,25,26,27,-pentanor-vitamin d analogs
US9416102B2 (en) 2013-01-23 2016-08-16 Wisconsin Alumni Research Foundation (22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs
NZ714801A (en) 2013-05-29 2021-07-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
CN106279239B (zh) * 2015-05-29 2019-06-28 上海彩迩文生化科技有限公司 多烯化合物、制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206316B (en) * 1988-04-29 1992-10-28 Wisconsin Alumni Res Found Process for producing 1-alpha-hydroxy-d-vitamine homologues with unsaturated side-chain and pharmaceutical compositions containing them
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
FR2677022B1 (fr) * 1991-05-29 1995-03-10 Medgenix Group Sa Derives de la vitamine d comportant un groupe epoxyde sur la chaine laterale.
DE69213844T2 (de) * 1991-07-05 1997-04-10 Duphar Int Res Vitamin-D Derivat, Verfahren zu dessen Herstellung sowie Zwischenprodukte dafür
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
GB9214202D0 (en) * 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds

Also Published As

Publication number Publication date
IL116326A (en) 2000-08-13
US5929056A (en) 1999-07-27
DE69508895D1 (de) 1999-05-12
EP0717034A1 (en) 1996-06-19
DE69508895T2 (de) 1999-10-21
CA2164916A1 (en) 1996-06-15
JPH08319268A (ja) 1996-12-03
EP0717034B1 (en) 1999-04-07
ATE178596T1 (de) 1999-04-15
DK0717034T3 (da) 1999-10-18
IL116326A0 (en) 1996-03-31
JP4036490B2 (ja) 2008-01-23

Similar Documents

Publication Publication Date Title
ES2130522T3 (es) Compuestos de vitamina d y metodo para preparar estos compuestos.
DE3579404D1 (de) Therapeutischer verband und verfahren seiner herstellung.
CO4790150A1 (es) Inhibidores de metaloproteinasas, composiciones farmaceuti- cas que los contienen y sus farmaceuticos y los metodos e intermedios utiles para su preparacion
AR009357A1 (es) Compuesto de amidas de acido fosfinico y sus usos para preparar una composicion farmaceutica y en un metodo para prevenir o tratar unaenfermedad asociada a la actividad de metaloproteasa
SE8001685L (sv) Karcinostatiskt och immunostimulerande medel innehallande lysofosfolipid och fosfolipid och forfarande for framstellning derav
KR920007617A (ko) 화장제 조성물
NO304945B1 (no) Forbindelse og anvendelse derav for Õ regulere fethet i hud, samt kosmetisk blanding
ES2080764T3 (es) Derivados de acidos biliares fluorados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
IT1000535B (it) Procedimento per la preparazione di pelli purificate pronte per la concia da pelli animali
TR22674A (tr) Su gecirmez derilerin veya kuerklerin ueretilmesine mahsus usul
ES2189992T3 (es) Reduccion del crecimiento del pelo.
ES499782A0 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
IT7848175A0 (it) Procedimento per produrre dispersioni acquose modificate di materie plastiche poliuretaniche
AR217878A1 (es) Composicion para regular el crecimiento de plantas leguminosas,que contienen acidos 3-aril-4-isotiazolcarboxilicos o acidos 3-aril-4-isoxazolcarboxilicos
ES500295A0 (es) Metodo para el cultivo de microorganismos
PT68044B (de) Verfahren zur herstellung neuer derivate des alkylendiamins
ES519982A0 (es) Procedimiento para preparar -monohidrato de (+)-catequina.
ES2061964T3 (es) Compuestos de diamina.
BR8202494A (pt) Processo para preparar tecido natural fixo bem como tecido natural fixo valvula cardiaca fixa de suino e tecido fixo de pericardio de bovino adequados para implante
ES2080311T3 (es) Nuevos derivados de escualeno de ciclopropilo y su utilizacion como inhibidor de sintesis del colesterol.
ES2106936T3 (es) Derivados de carbazolona y procedimientos para su preparacion.
ES551382A0 (es) Procedimiento para el tenido profundo de cuero curtido
GB1192576A (en) Diagnostic Substance and Composition
SE7612258L (sv) Djurvextregulerande medel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 717034

Country of ref document: ES